Every SEC Form 3/4/5 on record for this filer (CIK 1677618) — 5 issuers, 134 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| GENB | Generate Biomedicines, Inc. | Director | 2026-02-26 → 2026-03-02 | 2 | — |
| TECH | BIO-TECHNE Corp | Director | 2019-07-02 → 2025-11-03 | 10 | — |
| BMY | BRISTOL MYERS SQUIBB CO | EVP & President, Research · lapsed | 2019-11-27 → 2023-05-04 | 33 | −$36M |
| CELG | CELGENE CORP /DE/ | PRES., RESEARCH AND EARLY DEV. · lapsed | 2016-06-24 → 2019-11-22 | 23 | −$1M |
| JUNO | Juno Therapeutics, Inc. | Director · lapsed | 2017-04-19 → 2017-04-19 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| BMY | 2023-05-03 | Sell | 50,385 | $67.06 | $3M | 47,751 |
3 of 5 issuers are covered and open a security page; the rest are on file here only.